Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 11, Pages e0141919
Publisher
Public Library of Science (PLoS)
Online
2015-11-04
DOI
10.1371/journal.pone.0141919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Critical role of STAT3 in melanoma metastasis through anoikis resistance
- (2015) Neel M. Fofaria et al. Oncotarget
- Cross talk Initiated by Endothelial Cells Enhances Migration and Inhibits Anoikis of Squamous Cell Carcinoma Cells through STAT3/Akt/ERK Signaling
- (2015) Kathleen G. Neiva et al. NEOPLASIA
- A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
- (2015) Li Lin et al. NEOPLASIA
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
- (2014) Fei Ma et al. CANCER LETTERS
- STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells
- (2014) Neel M. Fofaria et al. CARCINOGENESIS
- STAT3 Target Genes Relevant to Human Cancers
- (2014) Richard Carpenter et al. Cancers
- Anoikis molecular pathways and its role in cancer progression
- (2013) Paolo Paoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
- (2013) Seog-Young Kim et al. CELLULAR SIGNALLING
- Therapeutic modulators of STAT signalling for human diseases
- (2013) Gabriella Miklossy et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
- (2013) Li Lin et al. PLoS One
- STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor
- (2013) Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species
- (2013) Jin Zhou et al. TOXICOLOGY LETTERS
- Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
- (2013) K H Koo et al. Cell Death & Disease
- Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
- (2012) K Ketola et al. BRITISH JOURNAL OF CANCER
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
- (2012) Pasquale Sansone et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer stem cells and their potential implications for the treatment of solid tumors
- (2012) B.A. Grotenhuis et al. JOURNAL OF SURGICAL ONCOLOGY
- Epigenetic alterations involved in cancer stem cell reprogramming
- (2012) Purificación Muñoz et al. Molecular Oncology
- Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
- (2012) Berlinda Verdoodt et al. PLoS One
- Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo
- (2012) Fan Wang et al. PLoS One
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- Overcoming anoikis - pathways to anchorage-independent growth in cancer
- (2011) M. C. Guadamillas et al. JOURNAL OF CELL SCIENCE
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
- (2010) Dominik Fuchs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy
- (2010) Frank A.E. Kruyt et al. BIOCHEMICAL PHARMACOLOGY
- Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation
- (2010) Hsiao-Ling Cheng et al. Molecular Cancer
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs
- (2009) Vasundhra Kashyap et al. STEM CELLS AND DEVELOPMENT
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started